Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
2295056
Title:
VERWENDUNG VON SNS-595 ZUR BEHANDLUNG VON LEUKÄMIA
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
101779510
WO application number:
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
2295056
WO publication number:
1rst applicant's nationality:
Translation language:
German
EPO publication language:
English
SPC number:
Dates
Filing date:
14/03/2005
Grant date:
06/01/2016
EP publication date:
16/03/2011
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
05/04/2016
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
06/01/2016
EP B1 publication date:
06/01/2016
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/03/2019
Expiration date (if granted and all annual fees paid):
14/03/2025
Applicant
1
Name:
Sunesis Pharmaceuticals, Inc.
Legal Form:
From:
06/01/2016
Address:
395 Oyster Point Blvd., Suite 400, South San Francisco, CA 94080, United States (US)
To:
2
Name:
Sumitomo Dainippon Pharma Co., Ltd.
Legal Form:
From:
06/01/2016
Address:
6-8, Dosho-machi 2-chome
Chuo-ku, Osaka-shi
Osaka 541-8524, Japan (JP)
Contains data concerning European patents granted for Belgium and published (B1 publication) in English and for which a translation in Dutch, French or German was filed under the Belgian Patent Laws
2
Bulletin heading:
VRV
Journal edition number:
2019/34
Publication date:
05/12/2019
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)
European Patent Bulletin
1
Issue number:
201601
Publication date:
06/01/2016
Description:
Grant (B1)
2
Issue number:
201604
Publication date:
27/01/2016
Description:
Inventor(s) changed
3
Issue number:
201606
Publication date:
10/02/2016
Description:
Application number/publication number of the divisional application (Art. 76) changed